Measurements of S100B in serum have been proven to valuably reflect the S100B concentration in cerebrospinal fluid (CSF) in healthy individuals as well as in patients with various neurological diseases (Reiber, 2001). The gene discussed is S100B; the disease is nervous system disorder.